ACMG Highlights

Hemoglobin S/C Newborn Screening ACT Sheet
Hemoglobin S/C Newborn Screening ACT Sheet

Learn More

Hemoglobin Variant Carrier Newborn Screening Algorithm
Hemoglobin Variant Carrier Newborn Screening Algorithm

Learn More

Hemoglobin S Newborn Screening Algorithm
Hemoglobin S Newborn Screening Algorithm

Learn More

Upcoming Events

ClinGen Somatic Cancer and VICC Virtual Molecular Tumor Board Case Series Webinar
Molecular Tumor Profiling in Oncology Patients with Multiple Genomic Variants
Tuesday, September 26, 11:00 am – 12:00 pm ET
Register here!
 

Interesting Cases from the Molecular Characterization Initiative (MCI)
Tuesday, October 24, 11:00 am – 12:00 pm ET
Register here!
 


2022 ACMG Summer Gene Therapy Education Series OnDemand
Did you miss a webinar? Don’t worry, you can find them here:
The recorded series is free to ACMG Members and $50 for Non-members.
1. The Basics of Gene Therapy: Preclinical Development
2. Gene Therapy Targets: Inborn Errors of Metabolism
3. Gene Therapy Targets: Broadening the Scope of Therapy
4. Gene Therapy: Ethical, Social and Economic Issues


New ACCME standards are now in effect as of January 1, 2022
Learn More


Medical Necessity Webinar Series OnDemand
Learn More


Evidence Based Guidelines Webinar Series
101: Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability
Available OnDemand
201: Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability
Available OnDemand


ACMG Genetics101 for Healthcare Providers
Learn More


2023 ACMG Annual Clinical Genetics Meeting Digital Edition
Learn More

News and Releases

The ACMG and ABMGG Issue Joint Response to the U.S. Supreme Court Ruling on Affirmative Action
ACMG-ABMGG Response SupremeCourt Affirmative Action 2023

Learn More

The ACMG Develops Guidance on Clinical Management of CHEK2 Pathogenic Variants and Cancer Risks
International Workgroup of Cancer Genetics Guidance on Clinical Management of CHEK2.T.Final.7.20

Learn More

ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
ACMG SF v3.2 Secondary Findings List: A 2023 Policy Statement of the ACMG

Learn More